New generations of hip and knee replacement implants offer little in terms of safety and durability compared with their older counterparts, according to a study published this week in The BMJ.
A meta-analysis of new generations of knee and hip replacement devices could bode ill for orthopedics makers.
In a study published this week in The BMJ, researchers warned that many innovative new implants may actually have worse durability and safety profiles than their predecessors.
Titan Spine offers patients a 1-time free replacement should they need revision for an implant from the Endoskeleton line of interbody fusion devices.
Titan Spine announced this week that it's offering a new series of warranties for its Endoskeleton line of interbody spinal fusion implants, promising a 1-time free revision surgery within 5 years.
A lawyer for the plaintiff in the 1st product liability trial over DePuy's Pinnacle hip replacement grills DePuy Synthes chairman Andrew Ekdahl, the former president of the Johnson & Johnson subsidiary that made the metal-on-metal implants.
The plaintiff's lawyer in the 1st DePuy Pinnacle hip implant lawsuit to go to trial yesterday grill former DePuy president Andrew Ekdahl on the witness stand, accusing him of helping to conceal the risk that the metal-on-metal hips could cause serious injury.
The 1st bellwether trial gets under way in product liability lawsuits filed over Johnson & Johnson subsidiary DePuy's Pinnacle line of metal-on-metal hip implants.
Another team of researchers is working on pacemakers that use motion for power, with aims to eliminate reliance on depletable batteries.
Swiss researchers are taking a page from their country's most iconic products to change how pacemakers are powered inside the body.
Boston Scientific reportedly wins the 2nd bellwether trial over its Obtryx pelvic mesh device, a month after winning the 1st personal injury case to go to trial over its transvaginal sling devices.
California's Sequent Medical begins enrolling patients in an IDE clinical trial of its Web aneurysm embolization system.
Medtech company Sequent Medical enrolled the 1st 4 patients in a new U.S. clinical trial aimed at winning FDA approval for its Web aneurysm protection implant.
The Web implant is made of a Nitinol mesh that is delivered in a "stent-like" manner and deployed into the pouch formed by an aneurysm in order to prevent blood from flowing in. The device already has approve in the European Union.